Weed (BUDZ) Other Non-Current Assets (2010 - 2012)

Weed (BUDZ) posted quarterly Other Non-Current Assets of $111500.0 for Q1 2012, up 913.64% quarter-over-quarter from $11000.0 in Q4 2011.

Weed (BUDZ) Other Non-Current Assets (2010 - 2012) Analysis & Trends

Weed's Other Non-Current Assets history runs 3 years deep, the most recent figure standing at $111500.0 for Q1 2012.

In Q1 2012, Other Non-Current Assets changed N/A year-over-year to $111500.0; the TTM figure through Mar 2012 stood at $111500.0 (changed N/A YoY), while the FY2011 annual figure was $11000.0, changed 0.0% from the prior year.
Other Non-Current Assets for Q1 2012 stood at $111500.0, up from $11000.0 in the prior quarter.
The five-year high for Other Non-Current Assets was $111500.0 in Q1 2012, with the low at $11000.0 in Q4 2010.
The 3-year median for Other Non-Current Assets is $108660.0 (2011), against an average of $70164.0.
Peak annual rise in Other Non-Current Assets reached 0.0% in 2011, while the deepest fall reached 0.0% in 2011.
Weed's Other Non-Current Assets stood at $11000.0 in 2010, then changed by 0.0% to $11000.0 in 2011, then surged by 913.64% to $111500.0 in 2012.
Business Quant data shows BUDZ's Other Non-Current Assets at $111500.0 in Q1 2012, $11000.0 in Q4 2011, and $108660.0 in Q3 2011.

#	Company	Market Cap	Enterprise Value	Gross Profit (Qtr)	Other Non-Current Assets (Qtr)
1	Haleon	43.91 Bn	42.95 Bn	-	56.35 Mn
2	Teva Pharmaceutical Industries	42.98 Bn	39.32 Bn	2.15 Bn	1.79 Bn
3	Zoetis	31.53 Bn	29.86 Bn	1.05 Bn	384.00 Mn
4	Takeda Pharmaceutical	28.61 Bn	22.81 Bn	5.10 Bn	503.80 Mn
5	United Therapeutics	22.16 Bn	19.49 Bn	683.80 Mn	239.50 Mn
6	Viatris	18.74 Bn	17.85 Bn	1.46 Bn	1.06 Bn
7	Neurocrine Biosciences	15.51 Bn	15.12 Bn	935.80 Mn	59.30 Mn
8	Elanco Animal Health	11.76 Bn	11.23 Bn	798.00 Mn	304.00 Mn
9	Dr Reddys Laboratories	10.12 Bn	9.95 Bn	-	13.00 Mn
10	Weed	2.88 Mn	2.88 Mn	-	-

Download Data